drugset / Trial / NCT06000410

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

NCT06000410 ↗

Phase 3 Completed 594 enrolled Organogenesis
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.

Timeline

Start
2023-09-06
Primary completion
2025-08-15
Completion
2025-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amniotic Suspension Allograft Other / unclassified 2 ml Other

Indications